Resources

3134 Resources for

HEALTHCARE

Subscribe to this listing via:
RSS
Email

Show All Related Tags Did you mean health care (2,100 results), health care company (18 results), Healthcare Financial Management Association (8 results), Tenet Healthcare Corp. (4 results), Allscripts Healthcare Solutions (3 results)more...

Show Fewer Related Tags Did you mean health care (2,100 results), health care company (18 results), Healthcare Financial Management Association (8 results), Tenet Healthcare Corp. (4 results), Allscripts Healthcare Solutions (3 results), Kindred Healthcare Inc. (2 results), Partners HealthCare System Inc. (1 results)fewer...

BNET Industries

Healthcare Services Group Inc.: Healthcare Services Group operates in two segments: housekeeping, which consists mainly of the cleaning, disinfecting and sanitizing of patient rooms and common areas of a...; Healthcare Services Group Inc. company page on BNET »

BNET Resources

Earnings Preview: IMS Health: IMS Health RX is scheduled to report Q2 earnings Monday, July 21 before market open, with a conference call scheduled for 8 am ET. Guidance Analysts are expecting a profit of 40c on revenue of $590.27M. The consensus range for EPS is 39c to 42c, with a revenue range of...; Tags: IMS Health Inc., Healthcare; External links 2008-07-18
Earnings Preview: Merck & Co.: Merck MRK is expected to report Q2 earnings Monday, July 21 before market open, with a conference call scheduled for 9:00 am ET. Guidance Analysts are looking for a profit of 83c on revenue of $6.05B. The consensus range is 80c to 85c for EPS, and revenue of $5.86B to...; Tags: Merck & Co. Inc., Healthcare; External links 2008-07-18
Earnings Preview: Schering-Plough Corp.: Schering-Plough SGP is expected to report Q2 earnings before market open Monday, July 21, with a conference call scheduled for 8:00 am ET. Guidance Analysts are looking for a profit of 41c on revenue of $4.77B. The consensus range is 28c to 48c for EPS, and revenue of $4.55B to...; Tags: Schering-Plough Corp., Healthcare; External links 2008-07-18
SMTS Has Some More Energy Left: Stockerati submits:Company Profile: Somanetics Corporation, SMTS incorporated in 1982, develops, manufactures and markets the In Vivo Optical Spectroscopy [INVOS] System, a non-invasive patient monitoring system that continuously measures changes in the blood oxygen levels in the brain and elsewhere in the body in somatic, or skeletal muscle, tissue in...; Tags: Healthcare, Somanetics Corp.; External links 2008-07-17
Health Care ETFs: Drugs and Devices Holding Their Own: Gary Gordon submits: Sometimes, bad news can be good news. Take biotech bellwether Genentech DNA. It missed Wall Street's expectations for earnings, yet it raised its guidance for future profitability. The entire biotech segment rallied on the news. And other times, good news can be... well,...; Tags: Biotech, ETF, Healthcare; External links 2008-07-17

Lev Acquisition Looks Good but More Clarity Needed: Dan Weiss submits: The portfolio's second acquisition of the year thus far, Lev Pharmaceuticals agreed to be acquired by Viropharma for approximately $2.75 per share comprised of $2.25 in cash and $0.50 in Viropharma stock (subject to a collar of between $10.03 to $15.68). In addition to this...; Tags: Healthcare; External links 2008-07-17
Merck Victorious over Apotex in Fosamax Counterclaims Case: Aaron F. Barkoff submits: Merck & Co. v. Apotex, No. 2007-1362 (Fed. Cir. 2008) Fosamax alendronate sodium is one of the all-time best-selling drugs for the treatment and prevention of osteoporosis, with over $3 billion in U.S. sales last year. Merck MRK listed ten patents in the Orange Book for Fosamax: ...; Tags: Merck & Co. Inc., Biotech, Healthcare; External links 2008-07-17
The Medicare-Bill Aftermath: Industry Implications: Congress overruled President Bush's veto of the latest Medicare bill, sealing a big victory for doctors over insurance companies. As we noted last week, the bill puts off an automatic cut in physician fees by limiting subsidies to insurance companies. (Paul Krugman, I should note, offered a take similar to...; Tags: HEALTHCARE, Insurance, David P. Hamilton, industry, Medicare, E-prescribing; Blog posts 2008-07-16
Johnson & Johnson a Compelling Investment: Mike Havrilla submits:Johnson & Johnson (NYSE: JNJ) 1-Year Chart vs. S&P 500 Index and Pharma HOLDRS PPH Johnson & Johnson JNJ reported record sales and profits that beat expectations for the 2Q08 before the market open yesterday. The stock has been a solid performer, illustrated in the 1-year chart above...; Tags: Johnson & Johnson, Healthcare; External links 2008-07-16
Earnings Preview: Stryker Corp.: Stryker Corp. SYK is expected to report Q2 earnings Thursday, July 17 after the market close with a conference call scheduled July 17 for 4:30 pm ET. Guidance Analysts are looking for a profit of 73c on revenue of 1.68B. The consensus range is 71c to 73c for EPS,...; Tags: Stryker Corp., Healthcare; External links 2008-07-16
Energy Sector Takes a Hit: Hickey and Walters Bespoke submit: Even the Energy sector has now turned negative. As shown in the charts below, the sector is now trading well below the bottom of its trading range, and only 5% of the stocks in it are trading above their 50-day moving averages. click...; Tags: Energy, Healthcare; External links 2008-07-16
Abbott Labs Reports Stellar Earnings, Poised to Break New Highs: Mike Havrilla submits: Abbott Labs ABT posted better than expected earnings and sales growth and raised its guidance this morning, reflected in the 1-year stock chart posted on my blog which shows that the company has outperformed the S&P 500 index by over 30% and the Healthcare Sector SPDR exchange-traded...; Tags: Healthcare, Abbott Laboratories Inc.; External links 2008-07-16
Earnings Preview: Baxter International: Baxter International BAX is expected to report Q2 earnings before market open on Thursday, July 17, with a conference call scheduled for 8:30 am ET. Guidance Analysts are looking for a profit of 82c on revenue of 3.05B. The consensus range is 80c to 82c for EPS, and revenue of...; Tags: Baxter International Inc., Healthcare; External links 2008-07-16
Earnings Preview: St. Jude Medical: St. Jude Medical STJ is scheduled to report earnings Wednesday, July 16 before market open, with a conference call scheduled for 8:00 am ET. Guidance Analysts are expecting a profit of 55c on revenue of $1.06B. The consensus range for EPS is 53c to 56c with a revenue range of...; Tags: St. Jude Medical Inc., Healthcare; External links 2008-07-15
Allos Therapeutics Looks Promising Ahead of Crucial 6 Months: EP Vantage submits: Allos Therapeutics’ ALTH lead drug PDX presents exactly the sort of niche opportunity that many drugmakers, and investors, are now chasing: a cancer therapy in an orphan indication, for which high prices can be justified. Growing optimism has driven shares in the US company higher in the...; Tags: Biotech, Healthcare, Allos Therapeutics Inc.; External links 2008-07-15
A Fat Yield at Pfizer: Mike Havrilla submits: With a dividend yield hovering around 7% and a recent deal with Indian generic drug maker Ranbaxy to delay a copycat version of the world's best selling drug Lipitor (with $12.7 billion in 2007 sales) for over one year until late 2011, shares of Pfizer PFE merit...; Tags: Pfizer Inc., Healthcare; External links 2008-07-15
Johnson & Johnson's Future Looks Bright: Devin Hobbes submits: Founded in 1886 and traded on the New York Stock Exchange since 1944, Johnson & Johnson JNJ is the largest and most diversified health care firm in the world. The company has raised dividends every year for the last 44 years. Its most recent dividend, in June,...; Tags: Johnson & Johnson, Healthcare; External links 2008-07-15
Earnings Preview: Abbott Laboratories: Abbott Laboratories ABT is expected to report Q2 earnings before market open on Wednesday, July 16, with a conference call scheduled July 16 for 9:00 am ET. Guidance Analysts are looking for a profit of 79c on revenue of $7.23B. The consensus range is 76c to 79c for EPS, and...; Tags: Abbott Laboratories Inc., Healthcare; External links 2008-07-15
Will Lehman's or Regions' Problems Sink the Angelica Buyout?: Thomas Kirchner submits: In the pending buyout of Angelica AGL, shareholders have not just the usual worry about the debt funding, but in an odd twist, the equity portion could also be at risk. The financing consists of equity from an entity affiliated with stressed Lehman LEH, while most...; Tags: Healthcare, Angelica Corp., Lehman Brothers Holdings Inc., Regions Financial Corp.; External links 2008-07-15
Summary Judgment in Seroquel Case Favors AstraZeneca; Teva and Sandoz to Appeal: Aaron F. Barkoff submits: AstraZeneca v. Teva Pharms. USA and Sandoz, No. 05-5333 (D.N.J. 2008) On July 1, the U.S. District Court for the District of New Jersey granted AstraZeneca's AZN motion for summary judgment that its patent on quetiapine fumarate, the active ingredient in Seroquel, is not unenforceable...; Tags: AstraZeneca Plc., Biotech, Healthcare; External links 2008-07-14